COX-2 inhibitors: lower risk of pancreatitis than other NSAIDs

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2006年 / 1116卷 / 1期
关键词：
Pancreatitis; Glucocorticoid; Acute Pancreatitis; Hospital Discharge; Celecoxib;
D O I：
10.2165/00128415-200611160-00008
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] Adverse effects of COX-2 inhibitors, nonselective NSAIDS
    不详
    GERIATRICS, 2006, 61 (11) : 9 - 9
  • [22] COX-2 inhibitors associated with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors
    van der Linden, Michiel W.
    Kuipers, Ernst J.
    Sukel, Myrthe P.
    Herings, Ron M.
    Gaugris, Sabine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S8 - S8
  • [23] COX-2 Inhibitors in Patients with Sensitivity to Nonselective NSAIDs
    Cimbollek, Stefan
    Quiralte, Joaquin
    Avila, Robledo
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (22): : 2197 - 2198
  • [24] Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension
    Frank Ruschitzka
    Current Hypertension Reports, 2007, 9 : 41 - 44
  • [25] Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension
    Ruschitzka, Frank
    Zhang, J.
    Ding, E. L.
    Song, Y.
    CURRENT HYPERTENSION REPORTS, 2007, 9 (01) : 41 - 44
  • [26] Selective COX-2 inhibitors vs NSAIDs discussed
    Reactions Weekly, 2002, 906 (1) : 3 - 3
  • [27] Chemoprevention strategies using NSAIDs and COX-2 inhibitors
    Keller, JJ
    Giardiello, FM
    CANCER BIOLOGY & THERAPY, 2003, 2 (04) : S140 - S149
  • [28] NSAIDS REVISITED CYCLOOXYGENASE-2 (COX-2) INHIBITORS
    JENSEN, NP
    MEDICINAL CHEMISTRY RESEARCH, 1995, 5 (05) : 319 - 324
  • [29] COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors
    van der Linden, Michiel W.
    Gaugris, Sabine
    Kuipers, Ernst J.
    van Herk-Sukel, Myrthe P. P.
    van den Bemt, Bart J. F.
    Sen, Shuvayu S.
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (10) : 880 - 890
  • [30] Use of COX-2 inhibitors, other NSAIDs, and the risk of myocardial infarction in three populations from UK, Canada, and the US
    Lewis, Michael A.
    Miller, Donald R.
    Rahme, Elham
    Kuehl-Habich, Doerthe
    Cunningham, Fran
    Kaufman, David W.
    Rosenberg, Lynn
    LeLorier, Jaques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S68 - S69
12345